Here is the latest update and chart of S&P BSE HEALTHCARE Index. For more details, see how the stocks in the S&P BSE HEALTHCARE are performing today. For a sector overview, read our pharmaceuticals sector report.
LAST CHANCE: Watch Rahul Shah Reveal the Potential 10X Opportunity
Live BSE Quotes | Jul 1, 2022 01:42:00 PM | ||
---|---|---|---|
Value21,677.83 | % Change 0.33 | 52-Week High 26,979.05 | 52-Week Low 20,847.55 |
Live NSE Quotes |
---|
Not listed |
Change | |||||
---|---|---|---|---|---|
1 Day 0.33% | 1 Month -2.38% | 3 Months -11.01% | 1 Year -15.83% | 5 Years (CAGR)* 8.79% | 10 Years (CAGR)* 12.07% |
* Compound Annual Growth Rate
BSE Sensex | CNX Nifty |
![]() |
||
PERIOD |
What else is happening in the markets today? Dig in...
Asian share markets erased early gains and fell in the negative territory tracking a sharp fall on Wall Street.
It came as a surprise to everyone when Sun Pharma reported a consolidated net loss in Q4 instead of a profit.
Here's why Divi's Lab's stock fell over 10% in two days.
For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.
During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.
The pandemic has opened up new opportunities for the Indian pharmaceutical sector. Which company is set to benefit from it?
More Views on NewsWith India's economic recovery accelerating, these sectors are likely to give multibagger returns in the future.
Constant product innovation, latest technology, strong supply chain etc can all help companies enjoy monopoly like fortunes.
This aspect of investing has a very high weightage on your overall returns, but often gets ignored when winning stories are written.
The #1 make or break factor in your portfolio you shouldn't ignore.
In this video I'll show you why I think the market correction could be coming to an end.
More